• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Omeros Corporation (OMER)

    -NasdaqGM
    20.87 Down 0.06(0.29%) Feb 27, 4:00PM EST
    |After Hours : 20.86 Down 0.01 (0.02%) Feb 27, 4:36PM EST
    Add to Portfolio
    Prev Close:20.93
    Open:20.81
    Bid:18.00 x 100
    Ask:N/A
    1y Target Est:40.40
    Beta:2.47
    Next Earnings Date:N/A
    Day's Range:20.68 - 21.13
    52wk Range:9.76 - 25.84
    Volume:901,416
    Avg Vol (3m):332,123
    Market Cap:711.15M
    P/E (ttm):N/A
    EPS (ttm):-1.70
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OMER

    Comparison

    Symbol% ChgMkt Cap
    OMERDown 0.29%711.15M
    ACADUp 0.50%3.79B
    ALKSDown 1.38%10.40B
    HRTXUp 3.26%379.05M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,350.74
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-2.21
    Quarterly EPS Est (Dec-14) :-0.60
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-0.11

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes products targeting inflammation, coagulopathies, and disorders of the central nervous system. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback